A study focusing on glioma stem-cell-like cells found that G0S2 regulates lipid droplet turnover and inhibits the E3 enzyme RNF168-mediated ubiquitination of 53BP1 through the mTOR-S6K signaling pathway. Here, TP53BP1 is linked to central nervous system cancer.